权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

A-to-I RNA modifications in mouse oocytes

小鼠卵母细胞中 A 至 I RNA 修饰

基本信息

批准号：
9805688
负责人：
Pavla Brachova
金额：
$ 11.74万
依托单位：
UNIVERSITY OF KANSAS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-26 至 2021-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9805688
关键词：
3&apos Untranslated Regions Adenosine Age Area Biochemical Bioinformatics Cells Code Codon Nucleotides Competence Congenital Abnormality Coupled Data Deamination Defect Development Disease Double-Stranded RNA Embryo Embryonic Development Environment Enzymes Female Fertility Fluorescent in Situ Hybridization Genetic Genetic Transcription Goals Growth Human Individual Infertility Inosine Knock-out Knowledge Maternal Age Maternal Messenger RNA Mediating Meiosis Mentors Mentorship Messenger RNA Modeling Modification Morula Mus Oocytes Oogenesis Partner in relationship Pattern Phase Polyribosomes Post-Transcriptional RNA Processing Post-Transcriptional Regulation Process Proteins RNA RNA Editing RNA Stability Regulation Reproduction Research Role Scientist Spontaneous abortion Tail Testing Training Transcript Translations Work adenosine deaminase age related aged blastocyst decapping enzyme dosage egg experimental study female fertility innovation mRNA Decay mRNA Stability mRNA Transcript Degradation male mutant novel oocyte quality recruit reproductive spleen exonuclease transcriptome transcriptomics zona pellucida glycoprotein

项目摘要

PROJECT SUMMARY/ABSTRACT The primary objective of this proposal is to facilitate the development of Dr. Brachova into an independent research scientist. This objective will be accomplished through a combination of active mentorship, didactic training, enrichment activities, and research. The mentorship phase is well described by her mentors and includes weekly contact and formal course work. The core of the research focuses on the role of a post- transcriptional regulation mechanism known as RNA editing in overall oocyte quality. Defects in oocyte growth and meiotic maturation represent a significant cause of human birth defects, miscarriage, and infertility. The contribution of RNA post-transcriptional modifications is emerging as an important regulator of RNA stability and oocyte quality, however the role of adenosine deaminase acting on double stranded RNA (ADAR1), which catalyzes the deamination of an adenosine (A) into inosine (I) remains unexplored. The goal of this research is to determine the effect of ADAR1 RNA editing on RNA stability and oocyte competence in young and old mice. Preliminary data show that ADARFL/FLZP3-Cre oocytes have reduced embryonic developmental potential, suggesting that ADAR1 is a novel factor that contributes to female fertility. We also show that oocytes and eggs from aged individuals have reduced RNA editing efficiency, suggesting that RNA editing deficiencies could be involved in female age-associated decline of fertility. The central hypothesis is that ADAR1 RNA editing is a novel mechanism for maintaining female fertility through the regulation of RNA stability during oocyte growth and early embryonic development. The hypothesis will be tested in two independent specific aims. Specific Aim 1 will assess the role of ADAR1 A-to-I RNA editing in the regulation of maternal mRNA dosage in the oocyte and early embryo. Specific Aim 2 will determine how ADAR1 A-to-I RNA editing effects mRNA degradation in oocytes. The proposed research will utilize oocytes and eggs from young and maternally aged mice to explore the role of A-to-I editing in oogenesis and age-related reduction in fertility. This proposal represents an innovative approach to study oocyte competence, and has the potential to expand our understanding of female fertility. Furthermore, the studies proposed herein are integral to enhance the scientific training of Dr. Brachova and enable her to accomplish her goal of achieving independence and becoming an independent scientist in the field of female reproduction.

项目总结/文摘